Transine Therapeutics raised €16M in a Seed round in Jun 2022. The company is based in Cambridge, UK. Investors in the round: Dementia Discovery Fund (DDF), Epidarex Capital, Mary Canning. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
